302 related articles for article (PubMed ID: 7724182)
1. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
[TBL] [Abstract][Full Text] [Related]
2. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
Arch Ophthalmol; 1995 Jan; 113(1):36-51. PubMed ID: 7826293
[TBL] [Abstract][Full Text] [Related]
3. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.
Arch Ophthalmol; 1998 Jul; 116(7):874-86. PubMed ID: 9682700
[TBL] [Abstract][Full Text] [Related]
4. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C
N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922
[TBL] [Abstract][Full Text] [Related]
6. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
7. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
[TBL] [Abstract][Full Text] [Related]
8. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
J Pediatr; 1994 Aug; 125(2):177-88. PubMed ID: 8040759
[TBL] [Abstract][Full Text] [Related]
9. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
[TBL] [Abstract][Full Text] [Related]
10. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group.
Ann Intern Med; 1995 Apr; 122(8):561-8. PubMed ID: 7887548
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
[TBL] [Abstract][Full Text] [Related]
12. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial.
Malone JI; Morrison AD; Pavan PR; Cuthbertson DD;
Diabetes Care; 2001 Mar; 24(3):522-6. PubMed ID: 11289479
[TBL] [Abstract][Full Text] [Related]
14. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).
The Diabetes Control and Complications Trial Research Group
Diabetologia; 1998 Apr; 41(4):416-23. PubMed ID: 9562345
[TBL] [Abstract][Full Text] [Related]
15. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
[TBL] [Abstract][Full Text] [Related]
16. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
[TBL] [Abstract][Full Text] [Related]
17. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Aiello LP;
Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
Shichiri M; Kishikawa H; Ohkubo Y; Wake N
Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
[TBL] [Abstract][Full Text] [Related]
19. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study.
Goldstein DE; Blinder KJ; Ide CH; Wilson RJ; Wiedmeyer HM; Little RR; England JD; Eddy M; Hewett JE; Anderson SK
Ophthalmology; 1993 Aug; 100(8):1125-31; discussion 1131-2. PubMed ID: 8341491
[TBL] [Abstract][Full Text] [Related]
20. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).
; Nathan DM; Zinman B; Cleary PA; Backlund JY; Genuth S; Miller R; Orchard TJ
Arch Intern Med; 2009 Jul; 169(14):1307-16. PubMed ID: 19636033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
